Intraocular Lens Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight
To read more about the latest highlights related to the Intraocular Lens Market, get a snapshot of the key highlights entailed in the Market Report @ Intraocular Lens Pipeline Products Market
Key Takeaways from the Intraocular Lens Pipeline Products Market
In April 2025, Berkeley Eye Center conducted a study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects.
The Global Intraocular Lens Market was valued at USD 3.85 billion in 2024, growing at a CAGR of 4.89% during the forecast period from 2025 to 2032 to reach USD 5.13 billion by 2032.
The Intraocular Lens Companies such as Johnson & Johnson, HOYA GROUP, Alcon Inc, Carl Zeiss Meditec AG, Bausch & Lomb, Rayner Intraocular Lenses Limited, Eyekon Medical Inc, Lenstec, Inc, HumanOptics AG, STAAR Surgical Company, Aurolab, PhyIOL S.A., Care Group, Tekia Inc, Omni Lens Pvt Ltd, MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses and others.
To know more about why North America is leading the market growth in the Intraocular Lens Pipeline Products Market, get a snapshot @ Intraocular Lens Market Outlook
Intraocular Lens Market Dynamics
The intraocular lenses market is experiencing increased product demand for a variety of reasons, one of the main reasons being the increase in the prevalence of ocular diseases. Increasing prevalence of eye diseases such as refractive error, age-related macular degeneration, cataracts, diabetic retinopathy, and glaucoma is a major driver of the intraocular lens market in particular. The majority of people over the age of 60 are affected by various types of eye problems that are chronic and require eye surgery. Visual impairment is a global health problem that affects physical and mental health. Visually impaired people are at particular risk of chronic illness, accidents, social withdrawal, depression, and death.
Intraocular Lens Market Segmentation
Intraocular Lenses Market by Product Type (Monofocal IOLs [Aspheric Monofocal IOLs and Spheric Monofocal IOLs], Premium IOLs [Multifocal IOLs, Accommodating IOLs, And Extended Depth-Of-Focus IOLs], and Others), by Material (Polymethyl Methacrylate, Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Ophthalmology Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Get a sneak peek at the Intraocular Lens Pipeline Products Market @ Intraocular Lens Market Dynamics Analysis
Intraocular Lens Companies
Johnson & Johnson, HOYA GROUP, Alcon Inc, Carl Zeiss Meditec AG, Bausch & Lomb, Rayner Intraocular Lenses Limited, Eyekon Medical Inc, Lenstec, Inc, HumanOptics AG, STAAR Surgical Company, Aurolab, PhyIOL S.A., Care Group, Tekia Inc, Omni Lens Pvt Ltd, MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses and others.
Intraocular Lens Market Drivers
The demand for intraocular lenses is witnessing a surge primarily due to the rising eye diseases prevalence, increasing initiatives by various governments across the globe in controlling and treating blindness, technological advancements in IOLs, and the increasing geriatric population who are more susceptible to ocular ailments which are expected to contribute in the growing product demand thereby boosting the growth of the of the intraocular lens market during the forecast period from 2025-2032.
Which MedTech key players in the Intraocular Lens Pipeline Products Market are set to emerge as the trendsetter explore @ Intraocular Lens Companies
Scope of the Intraocular Lens Market Report
Coverage- Global
Intraocular Lens Companies- Johnson & Johnson, HOYA GROUP, Alcon Inc, Carl Zeiss Meditec AG, Bausch & Lomb, Rayner Intraocular Lenses Limited, Eyekon Medical Inc, Lenstec, Inc, HumanOptics AG, STAAR Surgical Company, Aurolab, PhyIOL S.A., Care Group, Tekia Inc, Omni Lens Pvt Ltd, MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses and others.
Intraocular Lens Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
Interested in knowing the Intraocular Lens Market by 2032? Click to get a snapshot of the Intraocular Lens Market Trends
Table of Contents
1. Intraocular Lens Market Report Introduction
2. Intraocular Lens Market Executive Summary
3. Regulatory and Patent Analysis
4. Intraocular Lens Market Key Factors Analysis
5. Intraocular Lens Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Intraocular Lens Market
7. Intraocular Lens Market Layout
8. Intraocular Lens Market Global Company Share Analysis – Key 3-5 Companies
9. Intraocular Lens Market Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/intraocular-lens-market
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
19 minutes ago
- Globe and Mail
Class Action Lawsuit Filed: Fortrea Holdings Inc. (FTRE) - Join by August 1, 2025 - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - July 21, 2025) - If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ: FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Fortrea Holdings Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between July 3, 2023 and February 28, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Fortrea overestimated the amount of revenue the long-term projects in its portfolio, the Pre-Spin Projects, were likely to contribute to the Company's 2025 earnings; (ii) Fortrea overstated the cost savings it would likely achieve by exiting the transition services agreements; (iii) as a result, the Company's previously announced EBITDA targets for 2025 were inflated; (iv) accordingly, the viability of the Company's post-spin-off business model, as well as its business and/or financial prospects, were overstated; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times. WHAT'S NEXT? If you suffered a loss in Fortrea Holdings Inc. stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
Globe and Mail
19 minutes ago
- Globe and Mail
ITOS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iTeos Therapeutics, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of iTeos Therapeutics, Inc. (NASDAQ: ITOS) to Concentra Biosciences, LLC is fair to iTeos shareholders. Under the terms of the proposed transaction, Concentra will acquire iTeos for $10.047 in cash per share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of iTeos in excess of $475 million; and (ii) 80% of any net proceeds received from any disposition of certain of iTeos' product candidates that occurs within six months following the closing. Halper Sadeh encourages iTeos shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether iTeos and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for iTeos shareholders; (2) determine whether Concentra is underpaying for iTeos; and (3) disclose all material information necessary for iTeos shareholders to adequately assess and value the merger consideration. On behalf of iTeos shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
CTV News
19 minutes ago
- CTV News
What happens if Canada Post workers reject final offer
Video Canada Post spokesperson Jon Hamilton on what happens next if workers reject the Crown corporation's final offer.
